Advantage Alpha Capital Partners LP Tg Therapeutics, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $387 Million
- Q4 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 13,447 shares of TGTX stock, worth $415,243. This represents 0.1% of its overall portfolio holdings.
Number of Shares
13,447
Previous 22,379
39.91%
Holding current value
$415,243
Previous $523,000
22.75%
% of portfolio
0.1%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding TGTX
# of Institutions
371Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$482 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$352 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$284 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.6 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$86.3 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.49B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...